Results 281 to 290 of about 5,245,251 (341)

Implementing a CYP2C19-guided approach for prescribing dual antiplatelet therapy in acute coronary syndrome for patients undergoing percutaneous coronary intervention: a cost-effectiveness analysis

Mahboub-Ahari A, Hilton J, Rodrigues M, McDermott J, Body R, Newman WG, Payne K.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis

Lancet, The, 2021
BACKGROUND Whether guided selection of antiplatelet therapy in patients undergoing percutaneous coronary intervention (PCI) is effective in improving outcomes compared with standard antiplatelet therapy remains controversial.
Mattia Galli, Stefano Benenati, Davide Capodanno   +2 more
exaly   +2 more sources

Antiplatelet therapy after percutaneous coronary intervention: current status and future perspectives

Cardiovascular Intervention and Therapeutics, 2022
Masahiro Natsuaki, Shinjo Sonoda, Goro Yoshioka   +2 more
exaly   +2 more sources

Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium

Circulation, 2023
Antiplatelet therapy is the mainstay of pharmacologic treatment to prevent thrombotic or ischemic events in patients with coronary artery disease treated with percutaneous coronary intervention and those treated medically for an acute coronary syndrome ...
D. Capodanno, R. Mehran, M. Krucoff, U. Baber, Deepak L. Bhatt, P. Capranzano, J. Collet, T. Cuisset, G. De Luca, L. De Luca, A. Farb, Francesco Franchi, C. Gibson, J. Hahn, M. Hong, S. James, A. Kastrati, T. Kimura, P. Lemos, R. Lopes, Adrian Magee, R. Matsumura, S. Mochizuki, M. O’Donoghue, N. Pereira, S. Rao, F. Rollini, Y. Shirai, D. Sibbing, P. Smits, P. Steg, R. Storey, Jurrien ten Berg, M. Valgimigli, P. Vranckx, Hirotoshi Watanabe, S. Windecker, P. Serruys, R. Yeh, M. Morice, D. Angiolillo   +40 more
semanticscholar   +1 more source

Antiplatelet therapy in patients with conservatively managed spontaneous coronary artery dissection from the multicentre DISCO registry.

European Heart Journal, 2021
AIMS The role of antiplatelet therapy in patients with spontaneous coronary artery dissection (SCAD) undergoing initial conservative management is still a matter of debate, with theoretical arguments in favour and against its use.
E. Cerrato, F. Giacobbe, G. Quadri, F. Macaya, M. Bianco, R. Mori, C. Biolè, A. Boi, L. Bettari, C. Rolfo, F. Ferrari, G. Annibali, M. Scappaticci, M. Pavani, U. Barbero, D. Buccheri, C. Cavallino, P. Lombardi, C. Bernelli, F. D’Ascenzo, V. Infantino, A. Gambino, S. Cinconze, A. Rognoni, L. Montagna, I. Porto, G. Musumeci, J. Escaned, F. Varbella   +28 more
semanticscholar   +1 more source

Oral Antiplatelet Therapy After Acute Coronary Syndrome: A Review.

Journal of the American Medical Association (JAMA), 2021
Importance Acute coronary syndrome (ACS) is a major cause of morbidity and mortality in the United States with an annual incidence of approximately 1 million.
Hassan Kamran, H. Jneid, Waleed T. Kayani, S. Virani, G. Levine, Vijay Nambi, U. Khalid   +6 more
semanticscholar   +1 more source

Precision medicine in interventional cardiology: implications for antiplatelet therapy in patients undergoing percutaneous coronary intervention.

Pharmacogenomics (London), 2022
Precision medicine is a medical model that proposes the customization of medical treatments to the individual patient, as opposed to a one-drug-fits-all model.
M. Galli, L. Ortega‐Paz, Francesco Franchi, F. Rollini, D. Angiolillo   +4 more
semanticscholar   +1 more source